ライフサイエンスコーパス: palpable

1 s were detected mammographically and one was palpable.

2 range, 2-22 mm), and eight lesions (9%) were palpable.

3 ncerous breasts, of which 89 (50%) foci were palpable.

4 r size was 12 mm (range, 8-18 mm); four were palpable.

5 Palpable (1 mm3) tumors were detected an average of 9 da

6 -4 blockade worked synergistically to reject palpable 11A-1 and MC-38 tumors.

7 lation was 767 patients with 926 masses (476 palpable, 450 nonpalpable).

8 ere abdominal pain (37 patients [84%]) and a palpable abdominal mass (19 [43%]).

9 ssical paediatric triad of abdominal pain, a palpable abdominal mass and bloody stool.

10 t breast biopsy may be avoided in women with palpable abnormalities when both US and mammography depi

11 387 with nonpalpable abnormalities; 286 with palpable abnormalities) scheduled for excisional biopsy

12 Five women had palpable abnormalities, and the sixth had cancer detecte

13 graphically indeterminate lesions >1 cm, and palpable abnormalities.

14 Sensitivity was higher for palpable abnormalities; specificity was higher for nonpa

15 During a 4-year period, 829 patients with a palpable abnormality at presentation and combined negati

16 A negative mammographic and US finding of a palpable abnormality does not exclude breast cancer, but

17 ination, VAB was seen to have eliminated the palpable abnormality in seven (88%) of eight patients wi

18 ed in a carrier of the BRCA1 mutation with a palpable abnormality in the contralateral breast.

19 -cm spiculated lesion corresponding with the palpable abnormality, and ultrasonography confirms a sol

20 iagnosis of breast cancer in the area of the palpable abnormality.

21 count (ALC) and 11 (92%) of 12 patients with palpable adenopathy experiencing at least a 50% reductio

22 th clinical T1-T2 invasive breast cancer, no palpable adenopathy, and 1 to 2 SLNs containing metastas

23 physical examination were known did not have palpable adenopathy.

24 asound into critical care practice is almost palpable after reading the chapters making up this suppl

25 FNAB are valuable for the assessment of both palpable and clinically occult recurrent breast cancers

26 dence (77%) of breast tumors that were often palpable and developed in one or more glands after long

27 In the chronic animal, lesions were still palpable and firm (mean lesion volume, 11.67 cm(3); larg

28 tive, specific staging and stratification of palpable and nonpalpable abnormalities.

29 psy was performed in almost equal numbers of palpable and nonpalpable masses, only 11% of palpable BI

30 The ALND rate did not vary between palpable and nonpalpable tumors.

31 At US, consecutive masses, palpable and nonpalpable, categorized as BI-RADS 3, 4, a

32 tures, nodes were divided into three groups: palpable and nonpalpable, palpable, and nonpalpable.

33 Both the age at which these tumors became palpable and subsequent tumor growth were indistinguisha

34 n = 242), and those in which the masses were palpable and who underwent biopsy without imaging guidan

35 t frequent clinical presentation of DM was a palpable and/or indurated lesion located on sun-exposed

36 Her spleen was not palpable, and a quantitative polymerase chain reaction (

37 menopausal, most primary tumors (62.6%) were palpable, and most operations (86.9%) were breast-conser

38 into three groups: palpable and nonpalpable, palpable, and nonpalpable.

39 All palpable, asymptomatic, anterior chest wall lesions were

40 clinical T1 or T2 invasive breast cancer, no palpable axillary adenopathy, and 1 or 2 sentinel lymph

41 T1 or T2 invasive primary breast cancer, no palpable axillary adenopathy, and 1 or 2 sentinel lymph

42 There was no palpable axillary adenopathy.

43 er outer quadrant of the left breast with no palpable axillary lymphadenopathy.

44 plicable to the identification of disease in palpable axillary nodes in patients with breast cancer a

45 For women with no suspicious, palpable axillary nodes who undergo breast-conserving th

46 kade prevented acute rejection and preserved palpable beating quality with reduced CD8 T-cell graft i

47 to determine whether the lesions were deemed palpable before and during surgery.

48 seven (88%) of eight patients with initially palpable benign masses.

49 palpable and nonpalpable masses, only 11% of palpable BI-RADS 3 and 4 masses were malignant, as compa

50 If there are palpable, biopsy-proven, or grossly apparent metastases

51 The percentage of mice with large palpable bladder lesions, which necessitated sacrifice o

52 appropriate for unconscious patients without palpable blood pressure or for those with controllable h

53 ecommended as the first diagnostic test of a palpable breast abnormality to distinguish simple cysts

54 wo groups of women undergoing lumpectomy for palpable breast cancer were studied, one group using int

55 We studied 1374 women with palpable breast cysts presenting between 1981 and 1987,

56 7% of women in the western world develop palpable breast cysts.

57 aise awareness and encourage more women with palpable breast lumps to seek and receive treatment in a

58 Physical examination reveals neither palpable breast mass nor axillary lymphadenopathy.

59 ammography does not help determine whether a palpable breast mass should be biopsied and should not a

60 men with diabetic mastopathy presented with palpable breast masses.

61 st cancer was discovered in 5% of women with palpable breast thickening.

62 nonpalpable (stage T1c) disease and 420 with palpable but clinically localized (stage T2) disease.

63 peaked at 14 days postinfection and was not palpable by 28 days postinfection.

64 thickened antropyloric muscle is not readily palpable can be difficult, resulting in delayed diagnosi

65 study was to determine whether the extent of palpable cancer within the prostate predicts outcome aft

66 and were smaller and lower in stage than 64 palpable cancers (P < .01) that were diagnosed in the re

67 cancers and smaller and lower in stage than palpable cancers in dense breasts.

68 T cells were given before the development of palpable carcinomas.

69 rV-CEA immunization of C57BL/6 mice bearing palpable CEA-positive colon adenocarcinoma tumors result

70 eceptor-related protein caused regression of palpable colon cancer xenograft tumors in some severely

71 dence rate of breast cancer in patients with palpable cysts was 2.81 (95% CI 2.17-3.59).

72 had risen to 10.0 ng/mL; there was still no palpable disease on digital rectal examination.

73 ndergoing total resection of all visible and palpable disease, 231 patients were randomly assigned to

74 nlarged, although he had no obvious areas of palpable disease.

75 ecipient mice, MT1-MMP-deficient tumors were palpable earlier than wild-type tumors.

76 aumatic onset, difficulty descending stairs, palpable effusion, fixed-flexion deformity, restricted-f

77 , aged 13, 15, and 16, were diagnosed due to palpable epigastric masses.

78 ed in 10% to 20% of patients presenting with palpable evidence of regional metastatic melanoma.

79 rom a wide range of disciplines, there was a palpable excitement at this conference brought about by

80 Patients with palpable extraprostatic disease (T3) have a poor prostat

81 The only discrete palpable finding was lumpectomy bed seroma.

82 the ability of the procedure to eliminate a palpable finding were evaluated with questionnaires and

83 that 1992 T2 subclassification derived from palpable findings improves prognostication over the 1997

84 wo patients with mammographically visible or palpable findings underwent T1- and fat-saturated T2-wei

85 Physical examination revealed a palpable firm mass occupying the entire left part of the

86 1989 to 1996 for evaluation of asymptomatic, palpable, focal, anterior chest wall lesions in otherwis

87 This examination was also notable for a palpable fullness within the right testicle.

88 d by recording the days required for loss of palpable graft contractions.

89 llografts treated with water survived (i.e., palpable heart beat) for 16.0+/-0.5 days (n=6).

90 Rejection as defined by the cessation of a palpable heartbeat was confirmed by histology.

91 as a 4- to 5-fold delay in the generation of palpable HYAL1-AS tumors, and the weight of HYAL1-AS tum

92 yable instrumentation, but has not yet had a palpable impact on improved detection limits.

93 bilateral in three of the five patients and palpable in four patients.

94 with a positive fine-needle aspiration of a palpable, ipsilateral axillary lymph node.

95 Case 1 was a 21-year-old woman with a palpable lesion in her right breast that was depicted as

96 fur colloid in four divided doses around the palpable lesion or immediately adjacent to the excision

97 Physical examination revealed a palpable lesion, 15 mm in diameter.

98 ake a successful cytologic FNAB diagnosis in palpable lesions vs nonpalpable lesions (successful diag

99 Seven palpable lesions were not visualized on mammograms.

100 s obtained at 90% sensitivity for women with palpable lesions when a discriminant based on age and th

101 evaluated for the presence of nonblanching, palpable lesions with a linear pattern.

102 in advance with emphasis on the presence of palpable lesions with a linear pattern.

103 vent the outgrowth of Bam1a tumor cells from palpable lesions, shrink established tumors, eliminate H

104 In palpable lesions, the sensitivity was of 94% with a spec

105 f celecoxib inhibited the formation of large palpable lesions.

106 e best test performances were for women with palpable lesions.

107 ion and survival was reduced in the earliest palpable LLC tumors extracted 6 days after implantation

108 iagnostic mammography was used to evaluate a palpable lump or nonpalpable breast abnormality, the pos

109 ncy." For fine-needle aspiration biopsy of a palpable lump performed by formally trained physicians,

110 axillary node dissection in patients with no palpable lymph nodes, compared with sentinel node biopsy

111 ients with T1-2 primary breast cancer and no palpable lymphadenopathy were enrolled in the randomised

112 ients with T1-2 primary breast cancer and no palpable lymphadenopathy.

113 ontinuously with E2, BN rats did not develop palpable mammary cancer during the 196-day course of E2

114 ANKL-induced salivary gland adenocarcinomas, palpable mammary tumors are not observed due to RANKL-su

115 o mice was associated with a lower number of palpable mammary tumors compared with vehicle-treated mi

116 nduced mammary tumor model, the incidence of palpable mammary tumors was significantly lower in LID m

117 and Neu have a slightly earlier incidence of palpable mammary tumours than the MMTV-neu offspring and

118 A palpable mass (< or =1.2 cm in mean diameter) was elimin

119 Other examination findings included palpable mass (2/8), conjunctival chemosis (2/8), hyperg

120 Pain/irritation (42%), palpable mass (27%), and fever (12%) were the leading si

121 78%) tumors had clinical findings, including palpable mass (n = 29), associated nipple inversion or r

122 s with no change in size most commonly had a palpable mass (six of 25 patients [24%]) or normal findi

123 12 patients (58.3%), 3 (25.0%) of whom had a palpable mass and 2 (16.7%) of whom had incidental breas

124 6-year-old postmenopausal woman discovered a palpable mass at the one o'clock position of the left br

125 A healthy 38-year-old woman presents with a palpable mass at the two o'clock position of the left br

126 Case 1: A 72-year-old woman presents with a palpable mass detected during yearly physical examinatio

127 have progressive pelvic pain after menarche, palpable mass due to hemihaemato(metro)colpos or pelvic

128 nts were very pleased with the resolution of palpable mass effect and cosmetic results.

129 A physical examination was remarkable for a palpable mass in the abdomen.

130 Physical examination revealed a palpable mass in the epigastrium; scleral icterus was ab

131 of relative proptosis of the left eye and a palpable mass in the left superonasal orbit.

132 ar-old postmenopausal woman presented with a palpable mass of the right breast.

133 ital examination revealed a small left-sided palpable mass of the testis, compatible with an inguinal

134 Clinical examination revealed no palpable mass or axillary lymphadenopathy.

135 predict for the presence of cancer before a palpable mass was detected.

136 A palpable mass was noted in the suprapubic region, and a

137 re associated with a mammographically occult palpable mass).

138 Nineteen tumors manifested as a palpable mass, four manifested with progressive breast s

139 All patients presented with a palpable mass, nine of which were retroareolar.

140 ed ducts at closest margin, age, presence of palpable mass, presence of lobular neoplasia, nuclear gr

141 Seventeen tumors manifested with a palpable mass, two with diffuse enlargement of the breas

142 etroareolar carcinoma usually manifests as a palpable mass.

143 Thirteen had deep palpable masses that were clinically determined to be fi

144 50 years of age and for those patients with palpable masses who were older than 50.

145 ould effect the rejection of an established, palpable Meth A tumor.

146 guidelines for the extent of dissection for palpable MTC are not well established.

147 In this series, >75% of patients with palpable MTC had associated nodal metastases, which ofte

148 y-three patients underwent thyroidectomy for palpable MTC with immediate or delayed central and bilat

149 ns should be considered in all patients with palpable MTC.

150 There were no palpable neck nodes.

151 each of 145 axillary nodes in 135 women (74 palpable nodes in 69 women, 71 nonpalpable nodes in 66 w

152 e, or hormone-receptor-positive disease with palpable nodes or positive findings on sentinel-node bio

153 ques has made it possible to detect many non-palpable nodules, or "incidentalomas," in the thyroid.

154 Physical examination revealed a palpable nontender mass in the left groin area.

155 The tumor was palpable on digital rectal examination on the anterior w

156 Occult hernias are symptomatic but not palpable on physical examination.

157 randomized clinical trials (RCTs) of PST for palpable, operable breast cancer have been reported sinc

158 sent an acceptable alternative to women with palpable, operable tumors and an excellent arena for cli

159 tients with totally ischemic extremities (no palpable or Doppler pulse) more likely were to be amputa

160 Two hundred sixty-two new patients with palpable or mammographic abnormalities underwent MR imag

161 on is indicated in patients who present with palpable or needle biopsy-proven axillary metastases, pa

162 Nine mice with visible, palpable, or unknown metastatic lesions were entered int

163 tal number of urinary bladder cancers/mouse, palpable plus microscopic, by 77, 57, and 43% at dosages

164 All consecutive patients with melanoma with palpable, proven lymph node metastases (2003-2008) refer

165 with complaints of severe abdominal pain and palpable pulsatile abdominal mass located in the left ep

166 The palpation revealed epigastric pain and palpable pulsatile mass above the umbilicus.

167 tainment of any measurable blood pressure or palpable pulse for at least 1 h after cardiac arrest.

168 the absence of heart sounds by auscultation, palpable pulse, and breath sounds were the most common,

169 itiation of sirolimus, the patient developed palpable purpura on the bilateral lower extremities that

170 tis of childhood typically presenting with a palpable purpuric rash and frequently involving the rena

171 Another, perhaps less palpable, reality may also be interfering with progress-

172 This calls for a palpable realization of chimera states without any fine-

173 ed a higher incidence of local failure (LF) (palpable recurrence or positive rebiopsy).

174 ce or absence of microscopic nonpalpable and palpable regional lymph node metastasis.

175 sical examination including a visible tumor, palpable resistance and pain/blood during digital rectal

176 ing approximately 3 cm on exam, and multiple palpable right axillary lymph nodes.

177 Palpable RM-1 tumors, grown in the distal appendage of C

178 g murine CT26 colon tumor lung metastases or palpable s.c. tumors (>100 mm(3)) with recombinant Liste

179 phase or after primary tumors have reached a palpable size blunted metastasis, indicating that late m

180 ss than 5 s, non-severe injury mechanism, no palpable skull fracture, and acting normally according t

181 es on the head and neck, as well as multiple palpable soft pliable nontender subcutaneous tumors scat

182 At 48 weeks, the mean palpable spleen length had decreased by 56% with ruxolit

183 aemia, or bleeding at grade 3 or worse, with palpable spleen of at least 5 cm and without grade 2 or

184 Spleen response (>/=50% reduction in palpable spleen size) was inversely correlated with the

185 ound on routine examination to have a barely palpable spleen tip.

186 The responding patients with palpable spleens also had significant reductions in sple

187 Other main inclusion criteria were palpable splenomegaly (>/=5 cm below the left costal mar

188 Nine patients had palpable splenomegaly at the time of the liver spleen sc

189 with the exception of a higher prevalence of palpable splenomegaly in patients with fibrosis (P < .01

190 hout phlebotomy) with complete resolution of palpable splenomegaly or symptoms in the absence of a th

191 ged >/=18 years) with polycythaemia vera, no palpable splenomegaly, and hydroxyurea resistance or int

192 n level; frequency of thromboembolic events, palpable splenomegaly, and splenectomy; chemotherapy exp

193 HDI is highly effective for the treatment of palpable stage IIIB-C melanoma, and the findings of this

194 aging Committee (number of metastatic nodes, palpable status, ulceration, age, primary site, pT stage

195 n increased prevalence of prolonged GITT and palpable stools in the rectum at digital rectal examinat

196 Thirteen patients with 14 palpable submandibular masses, surgical and histologic c

197 an area of the prostate gland other than the palpable suspicious area that prompted the biopsy.

198 ng breast-conserving therapy who do not have palpable, suspicious lymph nodes, who have tumors 3.0 cm

199 Palpable swelling of regional lymph nodes is a common se

200 The palpable tendon friction rub is an easily detected, inex

201 Sonograms of 19 patients with palpable testicular masses who underwent biopsy were rev

202 , while incompletely understood, is far more palpable than Proteus and is (in most cases) much more r

203 Patients with prior biopsies at the site of palpable thickening accounted for most false-negative ma

204 astic balloon diameter used, and presence of palpable thrill following angioplasty were examined as p

205 rly hints of clinical successes to come were palpable throughout the meeting.

206 ation, a time when > or =80% of the mice had palpable TRAMP-C1 tumors.

207 that DBM-fed groups had a lower incidence of palpable tumor and high-grade prostatic intraepithelial

208 etastasis burden when administered following palpable tumor formation and metastasis development.

209 Efficacy was measured by the absence of palpable tumor formation.

210 mplantation, respectively, and 5-6 weeks for palpable tumor growth.

211 The mean time to first palpable tumor in mice which undergo at least one pregna

212 tastasis rates and more rapid emergence of a palpable tumor mass.

213 gle polycistronic transcript, we showed that palpable tumor penetrance decreased from 93.3% to 6.7% u

214 and were euthanized at age 12 months or when palpable tumor reached 1 cm(3).

215 amples takes approximately 2 h and growth of palpable tumor requires approximately 14 weeks.

216 f BCG-hIL2MUC1-immunized animals developed a palpable tumor with a slower rate of tumor growth (P < 0

217 of treatment was measured by the absence of palpable tumor.

218 temozolomide achieved complete remission of palpable tumors after only 30 days of therapy, lasting >

219 of the placebo-treated animals had developed palpable tumors and died, whereas 60% of the toremifene-

220 In contrast, palpable tumors and multifocal disease developed slower

221 osis of human breast cancers, but ~10-20% of palpable tumors are not detectable on mammograms and onl

222 ate experiments, the cumulative incidence of palpable tumors at 32 weeks of age in 20 untreated mice

223 systemically for 10 weeks, the incidence of palpable tumors at 32 weeks of age in untreated mice or

224 tat5a allele reduced the number of mice with palpable tumors at 7 months of age (67% from 100%, P<0.0

225 ft model, mPGES-1-overexpressed cells formed palpable tumors at earlier time points and developed lar

226 ential of NF-kappaB inhibition, we generated palpable tumors by orthotopic injection of PyVT cells an

227 After palpable tumors developed, the mice were divided into th

228 express MMP3 lost the capacity to establish palpable tumors following orthotopic injection into immu

229 lasma samples collected before occurrence of palpable tumors from a C3(1)-T triple negative mouse mod

230 SKI-606 prevented the appearance of palpable tumors in over 50% of the animals and stopped t

231 to test its efficacy in inhibiting growth of palpable tumors in patient-derived ovarian cancer xenogr

232 K-293 cells that did not express uPAR formed palpable tumors in severe combined immunodeficient mice;

233 In palpable tumors in this model, p53 stabilization and apo

234 gnificantly from the placebo group, in which palpable tumors initially presented at 17 weeks of age,

235 Three weeks later, after development of palpable tumors, all animals received an intratracheal i

236 ated after the transgenic mice had developed palpable tumors, significant tumor regression was induce

237 ct on the time required for the formation of palpable tumors, tumor angiogenesis, overall tumor archi

238 Appearance of palpable tumors, tumor expansion, and metastasis was ind

239 DNA phenotype is produced well in advance of palpable tumors.

240 nd by 33 weeks, all of the animals developed palpable tumors.

241 ctal carcinoma in situ, and low incidence of palpable tumors.

242 history like a long-term drug treatment or a palpable tumour should be approached differently.

243 ystemic therapy and the earlier detection of palpable tumours.

244 Mice were checked weekly for the presence of palpable urinary bladder masses.

245 Four were interval cancers that became palpable within 1 year of screening and were considered

246 or cell injection or after the tumors became palpable, without organ toxicity, changes in serum chemi